In another study, GQ1b administration to the hippocampus of 3xTg-AD mice was shown to reduce APP accumulation and tau phosphorylation, which were associated with decreased APP protein and increased phosphoGSK3β levels, respectively [38]. The gene discussed is MAPT; the disease is Alzheimer disease.